Production of 8 cytokines and chemokines was reduced in mice upon ponatinib treatment at day 5 post-infection, whereas the concentrations of IL-6, IL-10, MCP-1, Eotaxin, IL-12 (p40), and MIP-1β were not affected (Figure 5A). The gene discussed is CCL4; the disease is infection.